Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$178.30 – $264.30
25% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.21B | $1.44B | $1.91B | $2.89B | $3.49B | $2.78B | $2.78B | $2.97B |
| Cost of revenue | $582.6M | $692.2M | $907.4M | $1.33B | $1.66B | $1.54B | $1.57B | $1.62B |
| Gross profit | $629.6M | $748.3M | $1.00B | $1.55B | $1.82B | $1.23B | $1.21B | $1.34B |
| Gross margin | 51.9% | 51.9% | 52.5% | 53.8% | 52.0% | 44.4% | 43.4% | 45.3% |
| R&D | $60.6M | $79.2M | $84.5M | $110.5M | $151.8M | $153.1M | $144.1M | $132.6M |
| Operating income | $300.2M | $332.0M | $471.8M | $895.4M | $1.05B | $449.5M | $370.6M | $548.8M |
| EBITDA | $349.5M | $417.0M | $569.2M | $798.7M | $1.33B | $755.7M | $670.5M | $866.8M |
| Net income | $208.1M | $234.5M | $335.9M | $414.4M | $876.1M | $309.7M | $175.1M | $265.5M |
| Net margin | 17.2% | 16.3% | 17.6% | 14.4% | 25.1% | 11.2% | 6.3% | 9.0% |
| EPS (diluted) | 2.26 | 2.54 | 3.64 | 4.50 | 9.51 | 3.36 | 1.81 | 2.73 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $3.2B | $5.08 | $4.99–$5.19 | 1 |
| 2027 | $3.5B | $6.02 | $5.91–$6.15 | 1 |
| 2028 | $3.9B | $7.15 | $7.03–$7.30 | 1 |
| 2029 | $4.3B | $8.30 | $8.16–$8.48 | 1 |
Forward consensus · source: Financial Modeling Prep
SARTORIUS STEDIM BIOTECH
No one on the platform currently holds SDMHF.
No tracked institution reports a position in SDMHF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-04-01 | $0.6900 | 2026-04-02 |
| 2025-04-03 | $0.6900 | 2025-04-04 |
| 2024-04-02 | $0.6900 | 2024-04-04 |
| Execution date | Ratio |
|---|---|
| 2016-06-02 | 6-for-1 |
| 2005-06-16 | 5-for-1 |
| 2004-07-13 | 11-for-10 |
No one on the platform has traded SDMHF yet.
| $14.7B |
| — |
| SAUHFStraumann Holding AG | $133.72 | +0.00% | $21.3B | — |
| SAUHYStraumann Holding AG | $13.15 | -0.45% | $21.0B | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 95.2× earnings vs its 79.0× historical median P/E.
Fair value ≈ $166.00 · price $200.02 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.